Has Kulumani Sivarajan received payments from drug or device companies?

Yes. Drug and device makers reported $19,377 in general payments to Kulumani Sivarajan across 100 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kulumani Sivarajan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kulumani Sivarajan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kulumani Sivarajan

Hematology & Oncology · Joliet, ILNPI 1952396582

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,503 of the $19,377 with a category attached, or 90.3%. 41 manufacturers reported payments, led by AstraZeneca at 45.1% of the total. Reporting peaked in 2020 at $6,371 and has fallen 99.7% since, to $17 in 2023.

$19,377in general payments, 2019–2025

Across 100 payments — averaging $193.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$9K
GSK$2K
Beigene, Ltd.$2K
Bristol Myers Squibb$2K
Karyopharm Therapeutics Inc.$2K
Astrazeneca UK Limited$1K
plus $2K from 35 others

$54in research payments, 2019–2025

Across 1 payment — averaging $53.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Incyte Corporation$54

What the payments were for

Consulting fees$17,50390%
Speaking & faculty fees$2501%
Food & beverage$1,6248%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	10	$8,737
GSK	2	$2,491
Beigene, Ltd.	1	$1,800
Bristol Myers Squibb	2	$1,681
Karyopharm Therapeutics Inc.	1	$1,550
Astrazeneca UK Limited	1	$1,388
Novocure GmbH	1	$250
Novartis	11	$196
E.r. Squibb & Sons, L.L.C.	9	$192
Merck	6	$123
Incyte Corporation	3	$66
Lilly USA, LLC	3	$58
Johnson & Johnson(2 entities)	4	$57
Regeneron Healthcare Solutions, Inc.	2	$53
Astellas Pharma US Inc	3	$52
Daiichi Sankyo Inc.	3	$52
Eisai Inc.	3	$50
Global Blood Therapeutics, Inc.	2	$47
Bayer	3	$41
Sanofi	2	$36
Beigene USA, Inc.	2	$34
Rigel Pharmaceuticals, Inc.	2	$32
Pharmacyclics LLC, An Abbvie Company	2	$32
Seagen Inc.	2	$30
AMAG Pharmaceuticals, Inc.	2	$29
Exelixis Inc.	2	$28
Helsinn Therapeutics (U.S.), Inc.	2	$25
Deciphera Pharmaceuticals Inc.	1	$25
Organon	1	$24
Amgen	1	$22
Foundation Medicine, Inc.	1	$20
Myriad Genetic Laboratories, Inc.	1	$19
Sun Pharmaceutical Industries Inc.	1	$19
Genentech USA, Inc.	1	$19
Cardinal Health 414 LLC	1	$17
Ipsen Biopharmaceuticals, Inc	1	$15
Coherus Oncology, Inc.	1	$15
Pharmacosmos Therapeutics Inc.	1	$15
Aurobindo Pharma USA, Inc.	1	$13
Pfizer	1	$12
Tesaro, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CALQUENCE$5,575
LYNPARZA$3,053
BLENREP$2,475
Inrebic$1,663
XPOVIO$1,550
IMJUDO$1,388

How this compares

$19,377 in reported general payments places this provider in the 80th percentile of 580 hematology & oncology providers in Illinois.

See all hematology & oncology providers in Illinois →

Other hematology & oncology in Joliet

Mohamad Khair KhasawnehMaywood$998K
Michael BishopChicago$974K
Jamile ShammoChicago$910K
John BerryBerwyn$687K
Young Kwang ChaeChicago$563K
Irfan MirzaChicago$544K
Marina GarassinoChicago$397K
Tulio RodriguezZion$337K
Chih-Yi LiaoChicago$317K
Gary KayElk Grove Village$314K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →